Clinical Trial Update: Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib [Phase 2]

View source ↗

Summary

Phase 2 study assessing efficacy and safety of pomalidomide plus dexamethasone in patients with multiple myeloma who relapsed after lenalidomide and bortezomib …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Multiple Myeloma, Relapse After Use of Lenalidomide and Bortezomib | Phase 2 | Status: UNKNOWN